Review




Structured Review

Human Protein Atlas secretome dataset
NRG1 mediates COLEC12 high TAM-induced stemness and therapeutic resistance. (A) Overlap of genes upregulated in COLEC12 OE macrophages with the THPA <t>secretome.</t> Heatmap of the top 20 induced genes. qRT-PCR, immunoblot, and ELISA confirm increased NRG1 expression and secretion in COLEC12 OE THP-1 macrophages (n=3). (B) COLEC12 OE CM increases lenvatinib resistance in Huh7 cells, whereas NRG1 knockdown reverses this effect, as shown by IC50, CCK-8 proliferation, colony formation, and apoptosis assays (n=3). (C) Subcutaneous Huh7 xenografts (n=6) and orthotopic liver models were treated with intratumoral or intraperitoneal injections of Vector-CM, COLEC12 OE -CM, or COLEC12 OE +shNRG1#1-CM with/without lenvatinib, showing tumor images, volumes, weights, and liver/body weight ratios (n=6). (D) qRT-PCR of SOX2/OCT4/CD44/CD133 in Huh7 under indicated CM (n=3). Tumorsphere formation under indicated CM (n=3). (E) Limiting dilution assays in vitro (M, n=3) and in vivo (N, n=6 per group), showing stem cell or tumor-initiating frequencies. Data are presented mean±standard error of the mean. Two group comparisons used Student’s t-test; multiple groups used one-way ANOVA; tumor initiation used Kruskal–Wallis. NRG1, Neuregulin 1; COLEC12, Collectin Subfamily Member 12; THPA, The Human Protein Atlas ; CM, conditioned medium; COLEC12 OE , COLEC12-overexpressing. * P <0.05, ** P <0.01, *** P <0.001. Source data available.
Secretome Dataset, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/secretome+dataset/pmc13129746-62-9-13?v=Human+Protein+Atlas
Average 86 stars, based on 1 article reviews
secretome dataset - by Bioz Stars, 2026-07
86/100 stars

Images

1) Product Images from "COLEC12 high tumor-associated macrophages orchestrate lenvatinib resistance and cancer stemness in hepatocellular carcinoma via paracrine NRG1-HER2/HER3 signaling"

Article Title: COLEC12 high tumor-associated macrophages orchestrate lenvatinib resistance and cancer stemness in hepatocellular carcinoma via paracrine NRG1-HER2/HER3 signaling

Journal: Clinical and Molecular Hepatology

doi: 10.3350/cmh.2025.1059

NRG1 mediates COLEC12 high TAM-induced stemness and therapeutic resistance. (A) Overlap of genes upregulated in COLEC12 OE macrophages with the THPA secretome. Heatmap of the top 20 induced genes. qRT-PCR, immunoblot, and ELISA confirm increased NRG1 expression and secretion in COLEC12 OE THP-1 macrophages (n=3). (B) COLEC12 OE CM increases lenvatinib resistance in Huh7 cells, whereas NRG1 knockdown reverses this effect, as shown by IC50, CCK-8 proliferation, colony formation, and apoptosis assays (n=3). (C) Subcutaneous Huh7 xenografts (n=6) and orthotopic liver models were treated with intratumoral or intraperitoneal injections of Vector-CM, COLEC12 OE -CM, or COLEC12 OE +shNRG1#1-CM with/without lenvatinib, showing tumor images, volumes, weights, and liver/body weight ratios (n=6). (D) qRT-PCR of SOX2/OCT4/CD44/CD133 in Huh7 under indicated CM (n=3). Tumorsphere formation under indicated CM (n=3). (E) Limiting dilution assays in vitro (M, n=3) and in vivo (N, n=6 per group), showing stem cell or tumor-initiating frequencies. Data are presented mean±standard error of the mean. Two group comparisons used Student’s t-test; multiple groups used one-way ANOVA; tumor initiation used Kruskal–Wallis. NRG1, Neuregulin 1; COLEC12, Collectin Subfamily Member 12; THPA, The Human Protein Atlas ; CM, conditioned medium; COLEC12 OE , COLEC12-overexpressing. * P <0.05, ** P <0.01, *** P <0.001. Source data available.
Figure Legend Snippet: NRG1 mediates COLEC12 high TAM-induced stemness and therapeutic resistance. (A) Overlap of genes upregulated in COLEC12 OE macrophages with the THPA secretome. Heatmap of the top 20 induced genes. qRT-PCR, immunoblot, and ELISA confirm increased NRG1 expression and secretion in COLEC12 OE THP-1 macrophages (n=3). (B) COLEC12 OE CM increases lenvatinib resistance in Huh7 cells, whereas NRG1 knockdown reverses this effect, as shown by IC50, CCK-8 proliferation, colony formation, and apoptosis assays (n=3). (C) Subcutaneous Huh7 xenografts (n=6) and orthotopic liver models were treated with intratumoral or intraperitoneal injections of Vector-CM, COLEC12 OE -CM, or COLEC12 OE +shNRG1#1-CM with/without lenvatinib, showing tumor images, volumes, weights, and liver/body weight ratios (n=6). (D) qRT-PCR of SOX2/OCT4/CD44/CD133 in Huh7 under indicated CM (n=3). Tumorsphere formation under indicated CM (n=3). (E) Limiting dilution assays in vitro (M, n=3) and in vivo (N, n=6 per group), showing stem cell or tumor-initiating frequencies. Data are presented mean±standard error of the mean. Two group comparisons used Student’s t-test; multiple groups used one-way ANOVA; tumor initiation used Kruskal–Wallis. NRG1, Neuregulin 1; COLEC12, Collectin Subfamily Member 12; THPA, The Human Protein Atlas ; CM, conditioned medium; COLEC12 OE , COLEC12-overexpressing. * P <0.05, ** P <0.01, *** P <0.001. Source data available.

Techniques Used: Quantitative RT-PCR, Western Blot, Enzyme-linked Immunosorbent Assay, Expressing, Knockdown, CCK-8 Assay, Plasmid Preparation, In Vitro, In Vivo



Similar Products

86
Human Protein Atlas secretome dataset
NRG1 mediates COLEC12 high TAM-induced stemness and therapeutic resistance. (A) Overlap of genes upregulated in COLEC12 OE macrophages with the THPA <t>secretome.</t> Heatmap of the top 20 induced genes. qRT-PCR, immunoblot, and ELISA confirm increased NRG1 expression and secretion in COLEC12 OE THP-1 macrophages (n=3). (B) COLEC12 OE CM increases lenvatinib resistance in Huh7 cells, whereas NRG1 knockdown reverses this effect, as shown by IC50, CCK-8 proliferation, colony formation, and apoptosis assays (n=3). (C) Subcutaneous Huh7 xenografts (n=6) and orthotopic liver models were treated with intratumoral or intraperitoneal injections of Vector-CM, COLEC12 OE -CM, or COLEC12 OE +shNRG1#1-CM with/without lenvatinib, showing tumor images, volumes, weights, and liver/body weight ratios (n=6). (D) qRT-PCR of SOX2/OCT4/CD44/CD133 in Huh7 under indicated CM (n=3). Tumorsphere formation under indicated CM (n=3). (E) Limiting dilution assays in vitro (M, n=3) and in vivo (N, n=6 per group), showing stem cell or tumor-initiating frequencies. Data are presented mean±standard error of the mean. Two group comparisons used Student’s t-test; multiple groups used one-way ANOVA; tumor initiation used Kruskal–Wallis. NRG1, Neuregulin 1; COLEC12, Collectin Subfamily Member 12; THPA, The Human Protein Atlas ; CM, conditioned medium; COLEC12 OE , COLEC12-overexpressing. * P <0.05, ** P <0.01, *** P <0.001. Source data available.
Secretome Dataset, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/secretome+dataset/pmc13129746-62-9-13?v=Human+Protein+Atlas
Average 86 stars, based on 1 article reviews
secretome dataset - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Human Protein Atlas hpa secretome dataset
NRG1 mediates COLEC12 high TAM-induced stemness and therapeutic resistance. (A) Overlap of genes upregulated in COLEC12 OE macrophages with the THPA <t>secretome.</t> Heatmap of the top 20 induced genes. qRT-PCR, immunoblot, and ELISA confirm increased NRG1 expression and secretion in COLEC12 OE THP-1 macrophages (n=3). (B) COLEC12 OE CM increases lenvatinib resistance in Huh7 cells, whereas NRG1 knockdown reverses this effect, as shown by IC50, CCK-8 proliferation, colony formation, and apoptosis assays (n=3). (C) Subcutaneous Huh7 xenografts (n=6) and orthotopic liver models were treated with intratumoral or intraperitoneal injections of Vector-CM, COLEC12 OE -CM, or COLEC12 OE +shNRG1#1-CM with/without lenvatinib, showing tumor images, volumes, weights, and liver/body weight ratios (n=6). (D) qRT-PCR of SOX2/OCT4/CD44/CD133 in Huh7 under indicated CM (n=3). Tumorsphere formation under indicated CM (n=3). (E) Limiting dilution assays in vitro (M, n=3) and in vivo (N, n=6 per group), showing stem cell or tumor-initiating frequencies. Data are presented mean±standard error of the mean. Two group comparisons used Student’s t-test; multiple groups used one-way ANOVA; tumor initiation used Kruskal–Wallis. NRG1, Neuregulin 1; COLEC12, Collectin Subfamily Member 12; THPA, The Human Protein Atlas ; CM, conditioned medium; COLEC12 OE , COLEC12-overexpressing. * P <0.05, ** P <0.01, *** P <0.001. Source data available.
Hpa Secretome Dataset, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/secretome+dataset/pm41309504-412-20-17?v=Human+Protein+Atlas
Average 86 stars, based on 1 article reviews
hpa secretome dataset - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Human Protein Atlas hpa secretome datasets across diverse tissues
(A) Overview of proteomic and <t>secretome</t> datasets generated from biobank specimens and utilized from public sources. (B) Experimental workflow for identifying secreted molecules across the FT epithelium and their subclusters. (C and D) Venn diagrams comparing protein overlap between datasets: tissue secretome vs. public FT lavage secretome ( C ), and tissue secretome vs. EpCAM⁺ Lin - cell proteome ( D ). (E) Venn diagram showing overlap between the inferred EpCAM⁺ Lin - cell secretome (shared proteins from tissue secretome and EpCAM⁺ proteome) and the secretome of 2D-cultured cells. (F) UMAP of the integrated epithelial subset showing expression of a signature derived from all genes encoding proteins found in the EpCAM⁺ cell proteome. (G) UMAP displaying expression of a refined signature representing overlapping genes from the tissue secretome and EpCAM⁺ cell proteome. (H) Bar plot quantifying the number of secreted molecules from the tissue secretome detected across epithelial subclusters. (I) Electron microscopy (EM) image of an FT organoid showing secretory granules along the apical surface of multiciliated and secretory cells. Annotations: C = cilia; MV = microvilli; S = secretory granules. Scale bar, 10 µm. (J) Table listing the top 20 differentially expressed secretory molecules from each epithelial subcluster. Color shading reflects the presence of each gene’s protein product in the proteome and/or secretome datasets shown in panel B , indicating relative support across modalities. See Supplementary Figure 6 for additional related data .
Hpa Secretome Datasets Across Diverse Tissues, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/secretome+dataset/bio_rxiv__2025__09__23__677404-430-17-14?v=Human+Protein+Atlas
Average 86 stars, based on 1 article reviews
hpa secretome datasets across diverse tissues - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Human Protein Atlas human protein atlas secretome dataset
(A) Overview of proteomic and <t>secretome</t> datasets generated from biobank specimens and utilized from public sources. (B) Experimental workflow for identifying secreted molecules across the FT epithelium and their subclusters. (C and D) Venn diagrams comparing protein overlap between datasets: tissue secretome vs. public FT lavage secretome ( C ), and tissue secretome vs. EpCAM⁺ Lin - cell proteome ( D ). (E) Venn diagram showing overlap between the inferred EpCAM⁺ Lin - cell secretome (shared proteins from tissue secretome and EpCAM⁺ proteome) and the secretome of 2D-cultured cells. (F) UMAP of the integrated epithelial subset showing expression of a signature derived from all genes encoding proteins found in the EpCAM⁺ cell proteome. (G) UMAP displaying expression of a refined signature representing overlapping genes from the tissue secretome and EpCAM⁺ cell proteome. (H) Bar plot quantifying the number of secreted molecules from the tissue secretome detected across epithelial subclusters. (I) Electron microscopy (EM) image of an FT organoid showing secretory granules along the apical surface of multiciliated and secretory cells. Annotations: C = cilia; MV = microvilli; S = secretory granules. Scale bar, 10 µm. (J) Table listing the top 20 differentially expressed secretory molecules from each epithelial subcluster. Color shading reflects the presence of each gene’s protein product in the proteome and/or secretome datasets shown in panel B , indicating relative support across modalities. See Supplementary Figure 6 for additional related data .
Human Protein Atlas Secretome Dataset, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/secretome+dataset/bio_rxiv__2025__07__11__664238-112-21-18?v=Human+Protein+Atlas
Average 90 stars, based on 1 article reviews
human protein atlas secretome dataset - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Human Protein Atlas blood secretome dataset
(A) Overview of proteomic and <t>secretome</t> datasets generated from biobank specimens and utilized from public sources. (B) Experimental workflow for identifying secreted molecules across the FT epithelium and their subclusters. (C and D) Venn diagrams comparing protein overlap between datasets: tissue secretome vs. public FT lavage secretome ( C ), and tissue secretome vs. EpCAM⁺ Lin - cell proteome ( D ). (E) Venn diagram showing overlap between the inferred EpCAM⁺ Lin - cell secretome (shared proteins from tissue secretome and EpCAM⁺ proteome) and the secretome of 2D-cultured cells. (F) UMAP of the integrated epithelial subset showing expression of a signature derived from all genes encoding proteins found in the EpCAM⁺ cell proteome. (G) UMAP displaying expression of a refined signature representing overlapping genes from the tissue secretome and EpCAM⁺ cell proteome. (H) Bar plot quantifying the number of secreted molecules from the tissue secretome detected across epithelial subclusters. (I) Electron microscopy (EM) image of an FT organoid showing secretory granules along the apical surface of multiciliated and secretory cells. Annotations: C = cilia; MV = microvilli; S = secretory granules. Scale bar, 10 µm. (J) Table listing the top 20 differentially expressed secretory molecules from each epithelial subcluster. Color shading reflects the presence of each gene’s protein product in the proteome and/or secretome datasets shown in panel B , indicating relative support across modalities. See Supplementary Figure 6 for additional related data .
Blood Secretome Dataset, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/secretome+dataset/pmc10870445-148-7-4?v=Human+Protein+Atlas
Average 90 stars, based on 1 article reviews
blood secretome dataset - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


NRG1 mediates COLEC12 high TAM-induced stemness and therapeutic resistance. (A) Overlap of genes upregulated in COLEC12 OE macrophages with the THPA secretome. Heatmap of the top 20 induced genes. qRT-PCR, immunoblot, and ELISA confirm increased NRG1 expression and secretion in COLEC12 OE THP-1 macrophages (n=3). (B) COLEC12 OE CM increases lenvatinib resistance in Huh7 cells, whereas NRG1 knockdown reverses this effect, as shown by IC50, CCK-8 proliferation, colony formation, and apoptosis assays (n=3). (C) Subcutaneous Huh7 xenografts (n=6) and orthotopic liver models were treated with intratumoral or intraperitoneal injections of Vector-CM, COLEC12 OE -CM, or COLEC12 OE +shNRG1#1-CM with/without lenvatinib, showing tumor images, volumes, weights, and liver/body weight ratios (n=6). (D) qRT-PCR of SOX2/OCT4/CD44/CD133 in Huh7 under indicated CM (n=3). Tumorsphere formation under indicated CM (n=3). (E) Limiting dilution assays in vitro (M, n=3) and in vivo (N, n=6 per group), showing stem cell or tumor-initiating frequencies. Data are presented mean±standard error of the mean. Two group comparisons used Student’s t-test; multiple groups used one-way ANOVA; tumor initiation used Kruskal–Wallis. NRG1, Neuregulin 1; COLEC12, Collectin Subfamily Member 12; THPA, The Human Protein Atlas ; CM, conditioned medium; COLEC12 OE , COLEC12-overexpressing. * P <0.05, ** P <0.01, *** P <0.001. Source data available.

Journal: Clinical and Molecular Hepatology

Article Title: COLEC12 high tumor-associated macrophages orchestrate lenvatinib resistance and cancer stemness in hepatocellular carcinoma via paracrine NRG1-HER2/HER3 signaling

doi: 10.3350/cmh.2025.1059

Figure Lengend Snippet: NRG1 mediates COLEC12 high TAM-induced stemness and therapeutic resistance. (A) Overlap of genes upregulated in COLEC12 OE macrophages with the THPA secretome. Heatmap of the top 20 induced genes. qRT-PCR, immunoblot, and ELISA confirm increased NRG1 expression and secretion in COLEC12 OE THP-1 macrophages (n=3). (B) COLEC12 OE CM increases lenvatinib resistance in Huh7 cells, whereas NRG1 knockdown reverses this effect, as shown by IC50, CCK-8 proliferation, colony formation, and apoptosis assays (n=3). (C) Subcutaneous Huh7 xenografts (n=6) and orthotopic liver models were treated with intratumoral or intraperitoneal injections of Vector-CM, COLEC12 OE -CM, or COLEC12 OE +shNRG1#1-CM with/without lenvatinib, showing tumor images, volumes, weights, and liver/body weight ratios (n=6). (D) qRT-PCR of SOX2/OCT4/CD44/CD133 in Huh7 under indicated CM (n=3). Tumorsphere formation under indicated CM (n=3). (E) Limiting dilution assays in vitro (M, n=3) and in vivo (N, n=6 per group), showing stem cell or tumor-initiating frequencies. Data are presented mean±standard error of the mean. Two group comparisons used Student’s t-test; multiple groups used one-way ANOVA; tumor initiation used Kruskal–Wallis. NRG1, Neuregulin 1; COLEC12, Collectin Subfamily Member 12; THPA, The Human Protein Atlas ; CM, conditioned medium; COLEC12 OE , COLEC12-overexpressing. * P <0.05, ** P <0.01, *** P <0.001. Source data available.

Article Snippet: We integrated COLEC12 OE macrophage transcriptomic data with the secretome dataset from The Human Protein Atlas (THPA) to identify potential mediators of COLEC12 high macrophage–induced stemness in HCC.

Techniques: Quantitative RT-PCR, Western Blot, Enzyme-linked Immunosorbent Assay, Expressing, Knockdown, CCK-8 Assay, Plasmid Preparation, In Vitro, In Vivo

(A) Overview of proteomic and secretome datasets generated from biobank specimens and utilized from public sources. (B) Experimental workflow for identifying secreted molecules across the FT epithelium and their subclusters. (C and D) Venn diagrams comparing protein overlap between datasets: tissue secretome vs. public FT lavage secretome ( C ), and tissue secretome vs. EpCAM⁺ Lin - cell proteome ( D ). (E) Venn diagram showing overlap between the inferred EpCAM⁺ Lin - cell secretome (shared proteins from tissue secretome and EpCAM⁺ proteome) and the secretome of 2D-cultured cells. (F) UMAP of the integrated epithelial subset showing expression of a signature derived from all genes encoding proteins found in the EpCAM⁺ cell proteome. (G) UMAP displaying expression of a refined signature representing overlapping genes from the tissue secretome and EpCAM⁺ cell proteome. (H) Bar plot quantifying the number of secreted molecules from the tissue secretome detected across epithelial subclusters. (I) Electron microscopy (EM) image of an FT organoid showing secretory granules along the apical surface of multiciliated and secretory cells. Annotations: C = cilia; MV = microvilli; S = secretory granules. Scale bar, 10 µm. (J) Table listing the top 20 differentially expressed secretory molecules from each epithelial subcluster. Color shading reflects the presence of each gene’s protein product in the proteome and/or secretome datasets shown in panel B , indicating relative support across modalities. See Supplementary Figure 6 for additional related data .

Journal: bioRxiv

Article Title: A Rare Multipotent Peg-like Epithelial Cell is a Candidate Cell-of-Origin for High-Grade Serous Ovarian Cancer

doi: 10.1101/2025.09.23.677404

Figure Lengend Snippet: (A) Overview of proteomic and secretome datasets generated from biobank specimens and utilized from public sources. (B) Experimental workflow for identifying secreted molecules across the FT epithelium and their subclusters. (C and D) Venn diagrams comparing protein overlap between datasets: tissue secretome vs. public FT lavage secretome ( C ), and tissue secretome vs. EpCAM⁺ Lin - cell proteome ( D ). (E) Venn diagram showing overlap between the inferred EpCAM⁺ Lin - cell secretome (shared proteins from tissue secretome and EpCAM⁺ proteome) and the secretome of 2D-cultured cells. (F) UMAP of the integrated epithelial subset showing expression of a signature derived from all genes encoding proteins found in the EpCAM⁺ cell proteome. (G) UMAP displaying expression of a refined signature representing overlapping genes from the tissue secretome and EpCAM⁺ cell proteome. (H) Bar plot quantifying the number of secreted molecules from the tissue secretome detected across epithelial subclusters. (I) Electron microscopy (EM) image of an FT organoid showing secretory granules along the apical surface of multiciliated and secretory cells. Annotations: C = cilia; MV = microvilli; S = secretory granules. Scale bar, 10 µm. (J) Table listing the top 20 differentially expressed secretory molecules from each epithelial subcluster. Color shading reflects the presence of each gene’s protein product in the proteome and/or secretome datasets shown in panel B , indicating relative support across modalities. See Supplementary Figure 6 for additional related data .

Article Snippet: A comprehensive reference list of human secreted proteins was compiled from multiple sources: (1) Human Protein Atlas (HPA) secretome datasets across diverse tissues, (2) reviewed UniProt entries annotated as secreted, (3) FT lavage proteome data, (4) 2D cultured PAX8+ epithelial cell secretome, (5) 2D cultured P0 FT epithelial cell secretome (6) fresh tissue secretome, (7) FT EpCAM+ cell proteome, (8) FT 3D organoid proteome and (9) a published FT proteome.

Techniques: Generated, Cell Culture, Expressing, Derivative Assay, Electron Microscopy